Inositol phosphates dynamically enhance stability, solubility, and catalytic activity of mTOR

Lucia E Rameh1, John D York2, Raymond D Blind3

  • 1Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, Alabama, USA; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

PubMed

Insights

Inositol phosphates, including inositol hexakisphosphate (IP6), dynamically regulate the mechanistic target of rapamycin (mTOR) kinase. These compounds enhance mTOR activity and promote a more stable, soluble active state, justifying further cellular studies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • Mechanistic target of rapamycin (mTOR) is a key regulator of cell growth and metabolism.
  • While mTOR is known to bind inositol hexakisphosphate (IP6), its precise functional role as a structural or catalytic regulator remains unclear.
  • Inositol phosphates (IPs) are diverse signaling molecules with various cellular functions.

Purpose of the Study:

  • To investigate the regulatory role of inositol phosphate species on mTOR and mTOR complex 1 (mTORC1) kinase activity.
  • To determine the impact of different inositol phosphate species on mTOR's catalytic efficiency and substrate phosphorylation.
  • To explore the potential of inositol phosphates in modulating mTOR's structural and functional properties.

Main Methods:

  • In vitro kinase assays using purified mTOR and mTORC1 complexes.
  • Characterization of kinetic parameters (VMAX, KM) for ATP and peptide substrates.
  • Analysis of inositol phosphate effects on protein solubility and electrophoretic mobility.
  • Reversibility studies of inositol phosphate binding to mTOR.

Main Results:

  • Exogenously added inositol phosphates (IP6, IP5, IP4, IP3) enhance mTOR and mTORC1 kinase activity in vitro, with higher phosphorylation states being more potent.
  • IP6 increases VMAX and decreases apparent KM for ATP in mTOR, while stabilizing the active form of mTORC1 over time.
  • IP6 binding to mTOR is reversible and affects its electrophoretic mobility and solubility.
  • Inositol phosphates promote a more stable and soluble active state of mTORC1.

Conclusions:

  • Multiple inositol phosphate species dynamically regulate mTOR and mTORC1 activity.
  • Inositol phosphates enhance kinase function by promoting a stable, soluble active conformation.
  • These findings support further investigation into the cellular dynamics of inositol phosphate regulation of mTOR.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.0K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
49.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K